Skip to main content

Dialysis

An overview of market access challenges for hemodialysis and peritoneal dialysis in European countries.

fgfh

Procedure coding

Procedure coding for dialysis is well established in most European countries. The procedure codes for hemodialysis distinguish among different techniques (e.g., intermittent, prolonged intermittent, or continuous), the procedure duration, indications for treatment (acute or chronic dialysis), and the type of anticoagulation agent. For example, in France, there are specific CCAM codes for acute hemodialysis: code JVJF002 “Extrarenal treatment by hemodialysis, hemodiafiltration, or non-continuous hemofiltration for acute renal failure, per 24 hours” or code JVJF005 “Extrarenal treatment by hemodialysis, hemodiafiltration, or continuous hemofiltration for acute renal failure, per 24 hours”. 

The codes for peritoneal dialysis differ depending on the type of peritoneal dialysis. For example, in the Netherlands, there are codes for continuous ambulatory peritoneal dialysis (CAPD), including dialysis solutions (code 192061), and for continuous cycling peritoneal dialysis (CCPD), including dialysis solutions (code 192063).

Access to dialysis (vascular or peritoneal) is typically coded separately. The codes can differ depending on the shunt type and approach (open or percutaneous). For example, in England, there is a specific OPCS code for vascular access to hemodialysis – code L74.1 “Insertion of arteriovenous prosthesis”; to indicate the percutaneous approach to the procedure, the supplementary codes for the transluminal approach to the organ, depending on the anatomical site (e.g., code Y79.5 “Transluminal approach to organ through radial artery”) are used in addition to the primary code for the insertion of the arteriovenous prosthesis.

fgfh

Payment mechanism

The payment model for dialysis varies depending on the indication (acute or chronic dialysis) and the settings in which dialysis is provided. 

In many European countries, renal replacement therapy is usually included in the reimbursement for ICU care when a patient with acute kidney injury is admitted. 

Suppose hemodialysis for acute kidney injury is performed in hospital settings (when the patient is hospitalized in the relevant therapeutic unit and receives hemodialysis in a relevant dialysis unit as necessary). In that case, the hemodialysis sessions are either paid on top of the core payment category driven by the indication for admission (e.g., unbundled HRG in England, supplemental payment category in France, or additional reimbursement via ZE category in Germany), or the cost of dialysis is included in the core payment category (Italy, countries of Nordic region). In Germany, hemodialysis is reimbursed as an add-on via the ZE mechanism, which is paid on top of the DRG tariff. The amount of add-on reimbursement depends on the type of procedure, its duration, and the patient’s age. An intermittent or prolonged intermittent (lasting more than six hours) hemodialysis session is reimbursed with a tariff of €169 for patients aged >14 years and €357 for patients <15 years. As for continuous hemodialysis (with a treatment duration exceeding 24 hours), the tariff ranges from €286 to €30,839 depending on the duration of the procedure (from up to 24 hours to more than 2,400 hours).

In most European countries, chronic hemodialysis and peritoneal dialysis are reimbursed via specific payment categories that indicate the number of dialysis sessions in a given period or the settings in which the dialysis sessions are conducted. For example, in England, dialysis for chronic kidney disease with access via hemodialysis catheter for adults in hospital settings is reimbursed per session of hemodialysis via HRG LD01A “Hospital Haemodialysis or Filtration, with Access via Haemodialysis Catheter, 19 years and over” with locally agreed tariffs. The average unit cost per hemodialysis session allocated to the HRG LD01A is £213, based on historical cost data collected by NHS England from all NHS hospitals (National Cost Collection, 2023/24). The Best Practice Tariff (BPT) for this HRG is £148 per hemodialysis session for the 2025/26 financial year. 

In the Netherlands, there are separate DRGs for continuous ambulatory peritoneal dialysis with a coverage period of seven days depending on the settings: when the procedure is performed without hospitalization with overnight stay, it is reimbursed via DRG 140301019 “Continuous Ambulatory Peritoneal Dialysis (peritoneal lavage) per week for renal failure” with an average 2024 cost of €1,510, in hospital admission with an overnight stay, it is reimbursed via DRG 140301020 “Continuous Ambulatory Peritoneal Dialysis (peritoneal lavage) per week in hospitalization for renal failure” with an average 2024 cost of €4,240.

fgfh

Policy considerations

Due to high medical and social importance, acute and chronic dialysis may be subject to specific policies from payers or national decision-makers in countries where such frameworks exist. 

For example, in England, the national payer, NHS England, developed several so-called Service Specifications, including policies for intermittent hemodialysis and plasma exchange to treat acute kidney injury, assessment and preparation for renal replacement therapy, In Centre Hemodialysis (ICHD), hemodialysis to treat established renal failure performed in a patient’s home, peritoneal dialysis to treat established renal failure, hemodialysis delivering only dialysis away from base (DAFB), in which NHS England outlined patient pathways, eligible hospitals, responsibilities of various stakeholders, etc. 

National clinical guidelines and recommendations continue to be influential factors affecting dialysis services' utilization.

fgfh

Health technology assessment

Due to established reimbursement policies in European countries, hospital-based dialysis technologies rarely become subjects of HTA. The exceptions include novel portable/home-based dialysis systems and tools for access to dialysis procedures. For example, in 2021, the National Institute for Health and Care Excellence (NICE) published interventional procedure guidance on percutaneous endovascular forearm-arteriovenous fistula creation for hemodialysis access, which concluded that the procedure should only be used with special arrangements for clinical governance, consent, and audit or research. Evidence on the procedure's safety raised no major safety concerns; however, evidence on its efficacy was limited in quantity and quality.

fgfh

Future challenges 

Although dialysis services in many European countries have established reimbursement and funding, challenges remain in improving the conditions for dialysis provision and optimizing healthcare costs. These challenges can be addressed by adopting new payment models for dialysis technology. Additionally, advancements in technology for setting up dialysis access and expanding home-based services necessitate adjustments in payment mechanisms to fully leverage their unique technology and cost profiles.

MTRC has experience with more than 7 projects related to different types of dialysis in Europe.

News and insights

Med Tech-related health technology assessments from NIHR in January 2025

In January 2025, the National Institute for Health and Care Research (NIHR) in England released two Med Tech-related assessments in its HTA Journal, which concerned a clinical decision support tool for lower urinary tract symptom in men and multi-cancer early detection tests for general population screening. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs NICE guidance.

Med Tech-related technology assessments from NICE in January 2025

In January 2025, the National Institute for Health and Care Excellence (NICE) published two new Interventional Procedures Guidance (Transperineal laser ablation for lower urinary tract symptoms of benign prostatic hyperplasia, electrically stimulated intravesical therapy for interstitial cystitis or overactive bladder) and one new Early Value Assessment (Artificial intelligence technologies to help detect fractures on X-rays in urgent care). Furthermore, one new clinical guideline was published, and one was updated.

The 2025 version of the SwissDRG released

On December 12, 2024, the entity managing the DRG system in Switzerland, SwissDRG, published the final (billing) version of the 2025 DRG system. In total, 23 new DRGs related to cardiovascular, gastrointestinal, nephrology and urology, neurology and neurosurgery, obstetrics and gynecology, orthopedics, pulmonary and airways, and some other areas were introduced. Also, 17 new add-on reimbursement categories were implemented.

Get in touch

Contact us to discuss your needs and learn about our services